Replies to post #4546 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

German Compassionate Use Reimbursement Connected to European Price?

To some degree, I think NWBO's request for compassionate use status and Germany's upcoming decision regarding DCVAX-L compassionate use reimbursement will give us a good idea what the continent of Europe will pay for DCVAX-L.

Drugmakers are allowed to set a list price for a new innovative medicine for the first year it’s on the market; the association negotiates rebates after a cost-benefit assessment run by the Federal Joint Committee, the German body that makes drug reimbursement decisions.

Bloomberg

The revised law will make it clear that the list price isn’t what’s paid in Germany, she said. German prices are influential because other countries use them as a reference.

Bloomberg

http://www.bloomberg.com/news/2014-02-17/german-proposal-to-report-drug-prices-has-roche-concerned.html